Sign inGet started

ATRN

Protagenic Therapeutics, Inc. ewCIK 1022899 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
6

AI insights for ATRN PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for ATRN
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
ARMEN GARO HSee Remarks1$0$02016-06-17
Barrage KhalilDirector1$0$02016-06-17
Ekizian GregoryDirector1$0$02016-06-17
Stein Robert BenjaminDirector1$0$02016-06-17
Silverman JoshuaDirector1$0$02016-06-17
Arrow Alexander K.Chief Financial Officer3$72.8K$02016-06-17

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Stein Robert BenjaminDirector A Award2016-06-172016-06-2140,000$1.25 $50.0K240,000SEC↗
Barrage KhalilDirector A Award2016-06-172016-06-2145,000$1.25 $56.3K245,000SEC↗
Silverman JoshuaDirector A Award2016-06-172016-06-2145,000$1.25 $56.3K45,000SEC↗
ARMEN GARO HSee Remarks A Award2016-06-172016-06-21500,000$1.25 $625.0K4,239,168SEC↗
Arrow Alexander K.Chief Financial Officer A Award2016-06-172016-06-21140,000$1.25 $175.0K358,260SEC↗
Ekizian GregoryDirector A Award2016-06-172016-06-2245,000$1.25 $56.3K645,000SEC↗
Arrow Alexander K.Chief Financial Officer P Buy deriv2016-04-152016-05-1018,260$1.25 $22.8K118,260SEC↗
Arrow Alexander K.Chief Financial Officer P Buy deriv2016-04-152016-05-1040,000$1.25 $50.0K100,000SEC↗